slides · global inventory
Title
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 303,780
Current window 28,441-28,470
Pages 10,126
Rows per page 30
Component
28,441-28,470 of 303,780
01
This is a short-seller research note cover page/executive summary.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · Setup & Stakes2 hits
07
The slide uses a highly critical, investigative tone, framing the company as fraudulent and the drug as dangerous.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · Setup & Stakes2 hits
09
The slide uses a list-based structure to present evidence of drug toxicity, citing specific page ranges from a larger document.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · Setup & Stakes2 hits
10
The slide uses a structured list format to present three distinct areas of clinical concern, each with corresponding reference numbers.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · Setup & Stakes2 hits
11
The slide uses a narrative-based evidence approach to build a case against the drug's safety profile.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Monster2 hits
15
The slide uses a narrative structure to present evidence of corporate misconduct and operational failure.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Monster2 hits
16
Uses historical precedent (Enron/Skilling and Insys) to frame current events at Harmony (HRMY) as a potential fraud or legal violation.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Monster2 hits
17
The slide uses a narrative of 'fraud' to frame the company's management and reporting practices.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Monster2 hits
26
The slide uses a combination of narrative argument and a supporting table of pharmacologic approaches to justify the 'difficult' commercial landscape.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The MonsterLoop · Aha Moment2 hits
31
The slide argues that the patent claims are spurious because the inventors are the same as those who published the molecule in 2002, and PubChem shows prior art from 2006.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Struggle2 hits
49
Includes a process diagram showing the progression from hERG block to Torsades de Pointes.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The Struggle2 hits
53
The slide uses a historical precedent (Seldane/terfenadine recall) to frame the severity of a current drug's (pitolisant) safety profile, highlighting specific death and exposure statistics.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The VictoryLoop · The Reveal2 hits
59
The slide highlights a fundamental design constraint in medicinal chemistry.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller Beat · The VictoryLoop · The Reveal2 hits
71
The slide uses a combination of chemical structure diagrams, a tabular summary of clinical trial failures, and a pie chart showing the distribution of indications for failed trials.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 2 hits
76
The slide uses excerpts from scientific literature to frame the technical hurdles in CNS drug development.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 2 hits
110
The slide uses a 'before-after' or 'comparison' structure to highlight the exclusion criteria in two different trial papers.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 2 hits
118
The slide uses a 'black box' argument to challenge the validity of the sponsor's pharmacokinetic model.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 2 hits
136
Includes a linear regression equation Y=14.62*X+53.34 and a scatter plot with error bars.Harmony Biosciences (HRMY) · Scorpion Capital
Research note Short seller 2 hits
07
This is a continuation page of a larger activist report.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 2 hits
15
The slide uses quotes from UMD professors to undermine the credibility of IonQ's technology claims.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller Beat · The Problem with IonQ's Technology2 hits
17
The slide uses a quote from a Quanta Magazine article to support the activist thesis that the target company's technology is fundamentally broken.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller Beat · The Problem with IonQ's Technology2 hits
18
The slide uses a collage of four actual slides from IonQ's investor deck to support the claim of 'make-believe' projections.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller Beat · The Problem with IonQ's Technology2 hits
39
The slide uses direct quotes and highlights to frame the company's claims as 'brazen' or questionable.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller Beat · The Struggle to Overcome Technical ChallengesLoop · Aha Moment2 hits
46
The slide uses a 'CEO quote contradiction' framework to undermine management credibility.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 2 hits
77
Uses a direct quote from a 2020 trade article to expose the company's marketing claims.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 2 hits
100
The slide uses a screenshot of IonQ's website to contrast the company's claims with the activist's narrative.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 2 hits
101
The slide uses a screenshot of a website to highlight a discrepancy between marketing claims and historical data.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 2 hits
155
The slide uses a combination of narrative accusation and direct quotes from earnings materials to build a case of financial misrepresentation.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 2 hits
165
Uses a red arrow to connect the visual marketing material to the CEO's specific claims.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 2 hits
172
The slide uses a 'villain' framing by questioning the capacity of the subject to fulfill all stated obligations.IonQ Inc. (IONQ) · Scorpion Capital
Activist deck Short seller 2 hits